English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
you are here:
MARKETS

Fresenius Kabi Oncology Ltd.

BSE: 532545 | NSE: FKONCO | Series: NA | ISIN: INE575G01010 | SECTOR: Pharmaceuticals

| BSE 132.45 0.00 (0.00%) | |

BSE Live

Jan 02, 15:50
132.45 0.00 (0.00%)
Volume
No Data Available
0

  • Prev. Close

    132.45

  • Open Price

    132.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    132.45 (20430)

Fresenius Kabi Oncology is not traded on BSE in the last 30 days

NSE Live

Oct 13, 12:27
1035.00 902.50 (681.13%)
Volume
No Data Available
0

  • Prev. Close

    132.50

  • Open Price

    1030.60

  • Bid Price (Qty.)

    1033.80 (729)

  • Offer Price (Qty.)

    1035.87 (652)

Fresenius Kabi Oncology is not traded on NSE in the last 30 days

Company Facts - Fresenius Kabi Oncology

Registered Address

B - 310,
Som Datt Chambers - I,,Bhikaji Cama Place
New Delhi
Delhi
110066

Tel: 011-26105570
Fax: 011-26195965
Email: complianceofficer.india@fresenius-kabi.com
Website: http://www.fresenius-kabi-oncology.com
Group: MNC Associate

Registrars

M C S Ltd.
-

Tel:
Fax:
Email: 1
Website: N.A.

Management - Fresenius Kabi Oncology

NameDesignation
Rakesh Bhargava Non Executive Chairman
Dilip G Shah Ind. Non-Executive Director
Gerrit Steen Non Executive Director
Rajiv Lochan Jain Independent Director
NameDesignation
Peter F Nilsson Managing Director & CEO
Michael Schonhofen Non Executive Director
Naresh Trehan Ind. Non-Executive Director
Source : Dion Global Solutions Limited

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Fresenius Kabi Oncology Stock Price | Fresenius Kabi Stock Quote | Fresenius Kabi Results | Fresenius Kabi News | View All Related Searches
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347